We help investigators take their research from the bench to the bedside so that they can start helping patients sooner.
The Oncomine Comprehensive Assay v3 tests 161 genes for hotspot driver mutations, loss of function mutations in tumor suppressor genes, gene amplifications and gene fusions. With just a few unstained slides of tumor tissue, a full readout of the most important functional and therapeutically relevant genetic alterations can be produced within a week and at a cost lower than Foundation Medicine or Caris.
We have a variety of resources we can apply to tumor model evaluation including:
We like to have a phone discussion to fully understand your needs before preparing a quote for services. Contact us to discuss your project.